The DOI matches its Crossref record; 291 of the 291 references it cites were found in a registry or an index.
Tumor necrosis factor antagonist mechanisms of action: A comprehensive review
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
Rutgeerts, P., Sandborn, W. J., Feagan, B. G., Reinisch, W., Olson, A., Johanns, J., Travers, S., Rachmilewitz, D., Hanauer, S. B., Lichtenstein, G. R., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050516 · Cited by 3,902
Towards a network theory of the immune system.
Jerne, N. K. (1974) · PubMed · Cited by 3,362
Dvorak, H. F., Brown, L. F., Detmar, M. J., & Dvořàk, A. M. (1995) · Europe PMC (PubMed Central) · Cited by 3,115
Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis
Lipsky, P. E., van der Heijde, D. M. F. M., St. Clair, E. W., Furst, D. E., Breedveld, F. C., Kalden, J. R., Smolen, J. S., Weisman, M., Emery, P., Feldmann, M., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011303432202 · Cited by 2,996
Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes
Micheau, O., & Tschopp, J. (2003) · Cell · doi:10.1016/s0092-8674(03)00521-x · Cited by 2,738
Projection of an Immunological Self Shadow Within the Thymus by the Aire Protein
Anderson, M. S., Venanzi, E. S., Klein, L., Chen, Z., Berzins, S. P., Turley, S. J., von Boehmer, H., Bronson, R., Dierich, A., Benoist, C., et al. (2002) · Science · doi:10.1126/science.1075958 · Cited by 2,486
Bongartz, T., Sutton, A. J., Sweeting, M. J., Buchan, I., Matteson, E. L., & Montori, V. (2006) · JAMA · doi:10.1001/jama.295.19.2275 · Cited by 2,468
NF-κB functions as a tumour promoter in inflammation-associated cancer
Pikarsky, E., Porat, R. M., Stein, I., Abramovitch, R., Amit, S., Kasem, S., Gutkovich-Pyest, E., Urieli-Shoval, S., Galun, E., & Ben-Neriah, Y. (2004) · Nature · doi:10.1038/nature02924 · Cited by 2,430
Cytokine Pathways and Joint Inflammation in Rheumatoid Arthritis
Choy, E. H. S., & Panayi, G. S. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103223441207 · Cited by 2,249
Weinblatt, M. E., Kremer, J. M., Bankhurst, A. D., Bulpitt, K. J., Fleischmann, R. M., Fox, R. I., Jackson, C. G., Lange, M., & Burge, D. J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901283400401 · Cited by 2,085
Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease
Baert, F., Noman, M., Vermeire, S., Van Assche, G., D' Haens, G., Carbonez, A., & Rutgeerts, P. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020888 · Cited by 2,015
A cytokine-mediated link between innate immunity, inflammation, and cancer
Lin, W.-W., & Karin, M. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31537 · Cited by 1,940 · cited 1×
“In recent years, the link between cytokine-mediated immunity, inflammation, and cancer has been the focus of considerable attention (reviewed in Lin & Karin, 2007).”
BackgroundBreedveld, F. C., Weisman, M. H., Kavanaugh, A. F., Cohen, S. B., Pavelka, K., Vollenhoven, R. V., Sharp, J., Perez, J. L., & Spencer‐Green, G. T. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21519 · Cited by 1,785
Weinblatt, M. E., Keystone, E. C., Furst, D. E., Moreland, L. W., Weisman, M. H., Birbara, C. A., Teoh, L. A., Fischkoff, S. A., & Chartash, E. K. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10697 · Cited by 1,757
Klareskog, L., van der Heijde, D., de Jager, J. P., Gough, A., Kalden, J., Malaise, M., Mola, E. M., Pavelka, K., Sany, J., Settas, L., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15640-7 · Cited by 1,751
Self-citationA Comparison of Etanercept and Methotrexate in Patients with Early Rheumatoid Arthritis
Bathon, J. M., Martin, R. W., Fleischmann, R. M., Tesser, J. R., Schiff, M. H., Keystone, E. C., Genovese, M. C., Wasko, M. C., Moreland, L. W., Weaver, A. L., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011303432201 · Cited by 1,730
Hanauer, S. B., Sandborn, W. J., Rutgeerts, P., Fedorak, R. N., Lukas, M., MacIntosh, D., Panaccione, R., Wolf, D., & Pollack, P. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.030 · Cited by 1,715
Elliott, M. J., Maini, R. N., Feldmann, M., Kalden, J. R., Antoni, C., Smolen, J. S., Leeb, B., Breedveld, F. C., Macfarlane, J. D., Bijl, J. A., et al. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90628-9 · Cited by 1,682
Flynn, J. L., Goldstein, M. M., Chan, J., Triebold, K. J., Pfeffer, K., Lowenstein, C. J., Schrelber, R., Mak, T. W., & Bloom, B. R. (1995) · Immunity · doi:10.1016/1074-7613(95)90001-2 · Cited by 1,677
Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis.
Keffer, J., Probert, L., Cazlaris, H., Georgopoulos, S., Kaslaris, E., Kioussis, D., & Kollias, G. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb04978.x · Cited by 1,660
Maini, R. N., Breedveld, F. C., Kalden, J. R., Smolen, J. S., Davis, D., MACFARLANE, J. D., Antoni, C., Leeb, B. F., Elliott, M. J., Woody, J. N., et al. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199809)41:9<1552::aid-art5>3.0.co;2-w · Cited by 1,623
Moreland, L. W., Baumgartner, S. W., Schiff, M. H., Tindall, E. A., Fleischmann, R. M., Weaver, A. L., Ettlinger, R. E., Cohen, S., Koopman, W. J., Mohler, K., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707173370301 · Cited by 1,622
Busse, W. W., & Lemanske, R. F. (2001) · New England Journal of Medicine · doi:10.1056/nejm200102013440507 · Cited by 1,606
Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κB
Baldwin, A. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11991 · Cited by 1,434
Impaired On/Off Regulation of TNF Biosynthesis in Mice Lacking TNF AU-Rich Elements
Kontoyiannis, D., Pasparakis, M., Pizarro, T. T., Cominelli, F., & Kollias, G. (1999) · Immunity · doi:10.1016/s1074-7613(00)80038-2 · Cited by 1,344
Grell, M., Douni, E., Wajant, H., Löhden, M., Clauss, M., Maxeiner, B., Georgopoulos, S., Lesslauer, W., Kollias, G., Pfizenmaier, K., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90192-2 · Cited by 1,325
Dickkopf-1 is a master regulator of joint remodeling
Diarra, D., Stolina, M., Polzer, K., Zwerina, J., Ominsky, M. S., Dwyer, D., Korb, A., Smolen, J., Hoffmann, M., Scheinecker, C., et al. (2007) · Nature Medicine · doi:10.1038/nm1538 · Cited by 1,298
Anti-TNFα Therapy of Rheumatoid Arthritis: What Have We Learned?
Feldmann, M., & Maini, R. N. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.163 · Cited by 1,257
Compromised Function of Regulatory T Cells in Rheumatoid Arthritis and Reversal by Anti-TNFα Therapy
Ehrenstein, M. R., Evans, J. G., Singh, A., Moore, S., Warnes, G., Isenberg, D. A., & Mauri, C. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040165 · Cited by 1,252
Rothe, J., Lesslauer, W., Lötscher, H., Lang, Y., Koebel, P., Köntgen, F., Althage, A., Zinkernagel, R., Steinmetz, M., & Bluethmann, H. (1993) · Nature · doi:10.1038/364798a0 · Cited by 1,245
Treatment of Septic Shock with the Tumor Necrosis Factor Receptor:Fc Fusion Protein
Fisher, C. J., Agosti, J. M., Opal, S. M., Lowry, S. F., Balk, R. A., Sadoff, J. C., Abraham, E., Schein, R. M. H., & Benjamin, E. (1996) · New England Journal of Medicine · doi:10.1056/nejm199606273342603 · Cited by 1,241
The Tumor Necrosis Factor Ligand and Receptor Families
Bazzoni, F., & Beutler, B. (1996) · New England Journal of Medicine · doi:10.1056/nejm199606273342607 · Cited by 1,225
TNF/iNOS-Producing Dendritic Cells Mediate Innate Immune Defense against Bacterial Infection
Serbina, N. V., Salazar-Mather, T. P., Biron, C. A., Kuziel, W. A., & Pamer, E. G. (2003) · Immunity · doi:10.1016/s1074-7613(03)00171-7 · Cited by 1,175
Etanercept as Monotherapy in Patients with Psoriasis
Leonardi, C. L., Powers, J. L., Matheson, R. T., Goffe, B. S., Zitnik, R., Wang, A., & Gottlieb, A. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030409 · Cited by 1,175
Keystone, E. C., Kavanaugh, A. F., Sharp, J. T., Tannenbaum, H., Hua, Y., Teoh, L. S., Fischkoff, S. A., & Chartash, E. K. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20217 · Cited by 1,172
Pasparakis, M., Alexopoulou, L., Episkopou, V, & Kollias, G. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.4.1397 · Cited by 1,160
INFLIXIMAB AND METHOTREXATE IN THE TREATMENT OF RHEUMATOID ARTHRITIS
Ipsky, P. E. E. L., Illiam, E. W., Urst, D. A. E. F., Reedveld, C. B., Oachim, J., Alden, R. K., Osef, J., Molen, S. S., Eisman, M. I. W., Mery, P. A. E., et al. (2000) · Cited by 1,155
St. Clair, E. W., van der Heijde, D. M. F. M., Smolen, J. S., Maini, R. N., Bathon, J. M., Emery, P., Keystone, E., Schiff, M., Kalden, J. R., Wang, B., et al. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20568 · Cited by 1,143
BRENNAN, F. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90430-3 · Cited by 1,129
Banner, D. W., D'Arcy, A., Janes, W., Gentz, R., Schoenfeld, H.-J., Broger, C., Loetscher, H., & Lesslauer, W. (1993) · Cell · doi:10.1016/0092-8674(93)90132-a · Cited by 1,104
Hehlgans, T., & Pfeffer, K. (2005) · Immunology · doi:10.1111/j.1365-2567.2005.02143.x · Cited by 1,048
Moreira, A. L., Sampaio, E. P., Zmuidzinas, A., Frindt, P., Smith, K. A., & Kaplan, G. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.6.1675 · Cited by 1,045
Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α
Elliott, M. J., Maini, R. N., Feldmann, M., Long‐Fox, A., Charles, P., Katsikis, P., Brennan, F. M., Walker, J., Bijl, H., Ghrayeb, J., et al. (1993) · Arthritis & Rheumatism · doi:10.1002/art.1780361206 · Cited by 1,038
Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis.
Williams, R. O., Feldmann, M., & Maini, R. N. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.20.9784 · Cited by 989
Jovanović, D., Battista, J. A. D., Pelletier, J., Jolicoeur, F. C., He, Y., Zhang, M., Mineau, F., & Martel‐Pelletier, J. (1998) · PubMed · Cited by 973
Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis
Arend, W. P., & Dayer, J. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330302 · Cited by 949
Etanercept for active Crohn's disease: A randomized, double-blind, placebo-controlled trial
Sandborn, W. J., Hanauer, S. B., Katz, S., Safdi, M., Wolf, D. G., Baerg, R. D., Tremaine, W. J., Johnson, T., Diehl, N. N., & Zinsmeister, A. R. (2001) · Gastroenterology · doi:10.1053/gast.2001.28674 · Cited by 910
Antibody Pharmacokinetics and Pharmacodynamics
Lobo, E. D., Hansen, R. J., & Balthasar, J. P. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20178 · Cited by 909
Lymphoid neogenesis in chronic inflammatory diseases
Aloisi, F., & Pujol-Borrell, R. (2006) · Nature Reviews Immunology · doi:10.1038/nri1786 · Cited by 908
Baecklund, E., Iliadou, A., Askling, J., Ekbom, A., Backlin, C., Granath, F., Catrina, A. I., Rosenquist, R., Feltelius, N., Sundström, C., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21675 · Cited by 890
Self-citationJovanovic, D. V., Di Battista, J. A., Martel-Pelletier, J., Jolicoeur, F. C., He, Y., Zhang, M., Mineau, F., & Pelletier, J.-P. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.7.3513 · Cited by 867
A Domain in TNF Receptors That Mediates Ligand-Independent Receptor Assembly and Signaling
Chan, F. K.-M., Chun, H. J., Zheng, L., Siegel, R. M., Bui, K. L., & Lenardo, M. J. (2000) · Science · doi:10.1126/science.288.5475.2351 · Cited by 856
Mice deficient in tumor necrosis factor-α are resistant to skin carcinogenesis
Moore, R. J., Owens, D. M., Stamp, G., Arnott, C., Burke, F., East, N., Holdsworth, H., Turner, L., Rollins, B., Pasparakis, M., et al. (1999) · Nature Medicine · doi:10.1038/10552 · Cited by 839
Etanercept plus Standard Therapy for Wegener's Granulomatosis
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa041884 · Cited by 834
Mohler, K. M., Torrance, D. S., Smith, C. A., Goodwin, R. G., Stremler, K. E., Fung, V. P., Madani, H., & Widmer, M. B. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.3.1548 · Cited by 832
Evidence of a Role of Tumor Necrosis Factor α in Refractory Asthma
Berry, M. A., Hargadon, B., Shelley, M., Parker, D., Shaw, D. E., Green, R. H., Bradding, P., Brightling, C. E., Wardlaw, A. J., & Pavord, I. D. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa050580 · Cited by 826
TNF downmodulates the function of human CD4+CD25hi T-regulatory cells
Valencia, X., Stephens, G., Goldbach-Mansky, R., Wilson, M., Shevach, E. M., & Lipsky, P. E. (2006) · Blood · doi:10.1182/blood-2005-11-4567 · Cited by 781
Dixon, W. G., Watson, K., Lunt, M., Hyrich, K. L., Silman, A. J., & Symmons, D. P. M. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21978 · Cited by 751
Van den Brande, J. M. H., Braat, H., van den Brink, G. R., Versteeg, H. H., Bauer, C. A., Hoedemaeker, I., van Montfrans, C., Hommes, D. W., Peppelenbosch, M. P., & van Deventer, S. J. H. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00382-2 · Cited by 723
Infliximab Therapy in Patients with Chronic Sarcoidosis and Pulmonary Involvement
Baughman, R. P., Drent, M., Kavuru, M., Judson, M. A., Costabel, U., du Bois, R., Albera, C., Brutsche, M., Davis, G., Donohue, J. F., et al. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200603-402oc · Cited by 714
Construction and initial characterization of a mouse-human chimeric anti-TNF antibody
Knight, D. M., Trinh, H., Le, J., Siegel, S., Shealy, D., McDonough, M., Scallon, B., Moore, M. A., Vilcek, J., Daddona, P., et al. (1993) · Molecular Immunology · doi:10.1016/0161-5890(93)90106-l · Cited by 703
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
Furst, D. E., Keystone, E. C., Braun, J., Breedveld, F. C., Burmester, G. R., De Benedetti, F., Dörner, T., Emery, P., Fleischmann, R., Gibofsky, A., et al. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.146852 · Cited by 687
Infections in patients with rheumatoid arthritis treated with biologic agents
Listing, J., Strangfeld, A., Kary, S., Rau, R., von Hinueber, U., Stoyanova‐Scholz, M., Gromnica‐Ihle, E., Antoni, C., Herzer, P., Kekow, J., et al. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21386 · Cited by 681
Scallon, B. (1995) · Cytokine · doi:10.1006/cyto.1995.0029 · Cited by 675
Development of anti-TNF therapy for rheumatoid arthritis
Feldmann, M. (2002) · Nature Reviews Immunology · doi:10.1038/nri802 · Cited by 673
Binding and Functional Comparisons of Two Types of Tumor Necrosis Factor Antagonists
Scallon, B., Cai, A., Solowski, N., Rosenberg, A., Song, X.-Y., Shealy, D., & Wagner, C. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.2.418 · Cited by 672
Lymphoid Neogenesis in Rheumatoid Synovitis
Takemura, S., Braun, A., Crowson, C., Kurtin, P. J., Cofield, R. H., O’Fallon, W. M., Goronzy, J. J., & Weyand, C. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.2.1072 · Cited by 660
Carmona, L., Gómez‐Reino, J. J., Rodríguez‐Valverde, V., Montero, D., Pascual‐Gómez, E., Mola, E. M., Carreño, L., Figueroa, M., & BIOBADASER Group (2005) · Arthritis & Rheumatism · doi:10.1002/art.21043 · Cited by 656
Wolfe, F., & Michaud, K. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20311 · Cited by 644
Immunogenicity of engineered antibodies
Hwang, W. Y. K., & Foote, J. (2005) · Methods · doi:10.1016/j.ymeth.2005.01.001 · Cited by 630
Balkwill, F., & Coussens, L. M. (2004) · Nature · doi:10.1038/431405a · Cited by 627
DEVELOPMENT AND MATURATION OF SECONDARY LYMPHOID TISSUES
Fu, Y.-X., & Chaplin, D. D. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.399 · Cited by 616
Ritchlin, C. T., Haas-Smith, S. A., Li, P., Hicks, D. G., & Schwarz, E. M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16069 · Cited by 616
Lügering, A., Schmidt, M., Lügering, N., Pauels, H.-G., Domschke, W., & Kucharzik, T. (2001) · Gastroenterology · doi:10.1053/gast.2001.28702 · Cited by 588
Luther, S. A., Bidgol, A., Hargreaves, D. C., Schmidt, A., Xu, Y., Paniyadi, J., Matloubian, M., & Cyster, J. G. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.1.424 · Cited by 584
TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases
Feldmann, M., & Maini, R. N. (2003) · Nature Medicine · doi:10.1038/nm939 · Cited by 584
Incidence of Cancer Among Patients With Rheumatoid Arthritis
Gridley, G., McLaughlin, J. K., Ekbom, A., Klareskog, L., Adami, H.-O., Hacker, D. G., Hoover, R., & Fraumeni, J. F. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.4.307 · Cited by 581
Self-citationGottlieb, A. B., Evans, R., Li, S., Dooley, L. T., Guzzo, C. A., Baker, D., Bala, M., Marano, C. W., & Menter, A. (2004) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2004.02.021 · Cited by 581
Schreiber, S., Rutgeerts, P., Fedorak, R. N., Khaliq–Kareemi, M., Kamm, M. A., Boivin, M., Bernstein, C. N., Staun, M., Thomsen, O. Ø., & Innes, A. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.06.064 · Cited by 580
Saxne, T., Palladino, M. A., Heinegãrd, D., Talal, N., & Wollheim, F. A. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780310816 · Cited by 566
Bartelds, G. M., Wijbrandts, C. A., Nurmohamed, M. T., Stapel, S., Lems, W. F., Aarden, L., Dijkmans, B. A. C., Tak, P. P., & Wolbink, G. J. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.065615 · Cited by 562
Self-citationTak, P. P., Smeets, T. J. M., Daha, M. R., Kluin, P. M., Meijers, K. A. E., Brand, R., Meinders, A. E., & Breedveld, F. C. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400206 · Cited by 548
Self-citationInfliximab treatment induces apoptosis of lamina propria T lymphocytes in Crohn's disease
ten Hove, T. (2002) · Gut · doi:10.1136/gut.50.2.206 · Cited by 545
Low-Dose Methotrexate: A Mainstay in the Treatment of Rheumatoid Arthritis
Cronstein, B. N. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.2.3 · Cited by 535
Osteoclasts are essential for TNF-α–mediated joint destruction
Redlich, K., Hayer, S., Ricci, R., David, J.-P., Tohidast-Akrad, M., Kollias, G., Steiner, G., Smolen, J. S., Wagner, E. F., & Schett, G. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15582 · Cited by 531
Charles, P. J., Elliott, M. J., Davis, D., Potter, A. R., Kalden, J. R., Antoni, C., Breedveld, F. C., Js, S., Eberl, G., DeWoody, K. L., et al. (1999) · PubMed · Cited by 531
Maini, R. N., Breedveld, F. C., Kalden, J. R., Smolen, J. S., Furst, D., Weisman, M. H., St.Clair, E. W., Keenan, G. F., van der Heijde, D., Marsters, P. A., et al. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20159 · Cited by 514
Gordon, K. B., Langley, R. G., Leonardi, C., Toth, D., Menter, M. A., Kang, S., Heffernan, M., Miller, B., Hamlin, R., Lim, L., et al. (2006) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.05.027 · Cited by 510
Tumour necrosis factor and Crohn's disease.
Van Deventer, S. J. (1997) · Gut · doi:10.1136/gut.40.4.443 · Cited by 500
Howarth, P. H. (2005) · Thorax · doi:10.1136/thx.2005.045260 · Cited by 495
Compartmentalization of TNF Receptor 1 Signaling
Schneider-Brachert, W., Tchikov, V., Neumeyer, J., Jakob, M., Winoto-Morbach, S., Held-Feindt, J., Heinrich, M., Merkel, O., Ehrenschwender, M., Adam, D., et al. (2004) · Immunity · doi:10.1016/j.immuni.2004.08.017 · Cited by 485
The type 1 receptor (CD120a) is the high-affinity receptor for soluble tumor necrosis factor
Grell, M., Wajant, H., Zimmermann, G., & Scheurich, P. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.2.570 · Cited by 478
Han, J., Brown, T., & Beutler, B. (1990) · The Journal of experimental medicine · doi:10.1084/jem.171.2.465 · Cited by 477
Osteoclasts are essential for TNF-α-mediated joint destruction.
Redlich, K., Hayer, S., Ricci, R., David, J.-P., Tohidast-Akrad, M., Kollias, G., Steiner, G., Smolen, J. S., Wagner, E. F., & Schett, G. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215582 · Cited by 474
Wolbink, G. J., Vis, M., Lems, W., Voskuyl, A. E., De Groot, E., Nurmohamed, M. T., Stapel, S., Tak, P. P., Aarden, L., & Dijkmans, B. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21671 · Cited by 471
Self-citationRecruitment of TNF Receptor 1 to Lipid Rafts Is Essential for TNFα-Mediated NF-κB Activation
Legler, D. F., Micheau, O., Doucey, M.-A., Tschopp, J., & Bron, C. (2003) · Immunity · doi:10.1016/s1074-7613(03)00092-x · Cited by 466
Smolen, J. S., Han, C., Bala, M., Maini, R. N., Kalden, J. R., van der Heijde, D., Breedveld, F. C., Furst, D. E., Lipsky, P. E., & ATTRACT Study Group (2005) · Arthritis & Rheumatism · doi:10.1002/art.20982 · Cited by 462
Genestier, L., Paillot, R., Fournel, S., Ferraro, C., Miossec, P., & Revillard, J. P. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2676 · Cited by 459
NETWORK COMMUNICATIONS: Lymphotoxins, LIGHT, and TNF
Ware, C. F. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115719 · Cited by 441
Joosten, L. A. B., Helsen, M. M., Saxne, T., van de Loo, F. A. J., Heinegård, D. K., & van den Berg, W. B. (1999) · PubMed · Cited by 441
Cao, D., Malmström, V., Baecher‐Allan, C., Hafler, D., Klareskog, L., & Trollmo, C. (2003) · European Journal of Immunology · doi:10.1002/immu.200390024 · Cited by 439
Self-citationCharles, P., Elliott, M. J., Davis, D., Potter, A., Kalden, J. R., Antoni, C., Breedveld, F. C., Smolen, J. S., Eberl, G., deWoody, K., et al. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.3.1521 · Cited by 436
Smolen, J. S., Van Der Heijde, D. M. F. M., St.Clair, E. W., Emery, P., Bathon, J. M., Keystone, E., Maini, R. N., Kalden, J. R., Schiff, M., Baker, D., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21678 · Cited by 434
Chronic inflammation caused by lymphotoxin is lymphoid neogenesis.
Kratz, A., Campos-Neto, A., Hanson, M. S., & Ruddle, N. H. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.4.1461 · Cited by 431
Cellular localization of interleukin-8 and its inducer, tumor necrosis factor-alpha in psoriasis.
Nickoloff, B. J., Karabin, G. D., Barker, J. N., Griffiths, C. E. M., Sarma, V. J., Mitra, R. S., Elder, J. T., Kunkel, S. L., & Dixit, V. M. (1991) · PubMed Central · Cited by 430
Kotake, S., Udagawa, N., Hakoda, M., Mogi, M., Yano, K., Tsuda, E., Takahashi, K., Furuya, T., Ishiyama, S., Kim, K., et al. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200105)44:5<1003::aid-anr179>3.0.co;2-# · Cited by 420
Askling, J., Fored, C. M., Brandt, L., Baecklund, E., Bertilsson, L., Cöster, L., Geborek, P., Jacobsson, L. T., Lindblad, S., Lysholm, J., et al. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21137 · Cited by 419
Self-citationSt.Clair, E. W., Wagner, C. L., Fasanmade, A. A., Wang, B., Schaible, T., Kavanaugh, A., & Keystone, E. C. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10302 · Cited by 417
Taylor, P. C., Peters, A. M., Paleolog, E., Chapman, P. T., Elliott, M. J., McCloskey, R., Feldmann, M., & Maini, R. N. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200001)43:1<38::aid-anr6>3.0.co;2-l · Cited by 405
Joosten, L. A. B., Helsen, M. M. A., Saxne, T., van de Loo, F. A. J., Heinegård, D., & van den Berg, W. B. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.9.5049 · Cited by 405
A Lymphotoxin-β-Specific Receptor
Crowe, P. D., VanArsdale, T. L., Walter, B. N., Ware, C. F., Hession, C., Ehrenfels, B., Browning, J. L., Din, W. S., Goodwin, R. G., & Smith, C. A. (1994) · Science · doi:10.1126/science.8171323 · Cited by 396
Baecklund, E., Ekbom, A., Sparén, P., Feltelius, N., & Klareskog, L. (1998) · BMJ · doi:10.1136/bmj.317.7152.180 · Cited by 394
Self-citationEtanercept for the Treatment of Stage II and III Progressive Pulmonary Sarcoidosis
Utz, J. P., Limper, A. H., Kalra, S., Specks, U., Scott, J. P., Vuk-Pavlovic, Z., & Schroeder, D. R. (2003) · Chest · doi:10.1378/chest.124.1.177 · Cited by 390
Schiff, M. H., Burmester, G. R., Kent, J. D., Pangan, A. L., Kupper, H., Fitzpatrick, S. B., & Donovan, C. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.043166 · Cited by 390
Rennert, P. D., Browning, J. L., Mebius, R., Mackay, F., & Hochman, P. S. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.5.1999 · Cited by 388
Bendtzen, K., Geborek, P., Svenson, M., Larsson, L., Kapetanovic, M. C., & Saxne, T. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22214 · Cited by 384
Rheumatic diseases: the effects of inflammation on bone
Walsh, N. C., Crotti, T. N., Goldring, S. R., & Gravallese, E. M. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00338.x · Cited by 380
Antibodies to a soluble form of a tumor necrosis factor (TNF) receptor have TNF-like activity.
Engelmann, H., Holtmann, H., Brakebusch, C., Avni, Y. S., Sarov, I., Nophar, Y., Hadas, E., Leitner, O., & Wallach, D. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)77330-4 · Cited by 378
Tak, P. P., Taylor, P. C., Breedveld, F. C., Smeets, T. J. M., Daha, M. R., Kluin, P. M., Meinders, A. E., & Maini, R. N. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390702 · Cited by 377
Self-citationTNF Inhibition Rapidly Down-Regulates Multiple Proinflammatory Pathways in Psoriasis Plaques
Gottlieb, A. B., Chamian, F., Masud, S., Cardinale, I., Abello, M. V., Lowes, M. A., Chen, F., Magliocco, M., & Krueger, J. G. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.4.2721 · Cited by 372
Thorbecke, G. J., Shah, R., Leu, C. H., Kuruvilla, A. P., Hardison, A. M., & Palladino, M. A. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.16.7375 · Cited by 360
Aringer, M., Graninger, W. B., Steiner, G., & Smolen, J. S. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20576 · Cited by 342
Askling, J., Fored, C. M., Brandt, L., Baecklund, E., Bertilsson, L., Feltelius, N., Cöster, L., Geborek, P., Jacobsson, L. T., Lindblad, S., et al. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.062760 · Cited by 334
Self-citationPaleolog, E. M., Young, S., Stark, A. C., McCloskey, R. V., Feldmann, M., & Maini, R. N. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199807)41:7<1258::aid-art17>3.0.co;2-1 · Cited by 325
The transcription factor NF-κB: control of oncogenesis and cancer therapy resistance
Mayo, M. W., & Baldwin, A. S. (2000) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(00)00002-0 · Cited by 324
Möttönen, M., Heikkinen, J., Mustonen, L., Isomäki, P., Luukkainen, R., & Lassila, O. (2005) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2005.02754.x · Cited by 320
Kapetanovic, M. C., Saxne, T., Sjöholm, A., Truedsson, L., Jönsson, G., & Geborek, P. (2006) · Rheumatology · doi:10.1093/rheumatology/kei193 · Cited by 319
Zwerina, J., Hayer, S., Tohidast‐Akrad, M., Bergmeister, H., Redlich, K., Feige, U., Dunstan, C., Kollias, G., Steiner, G., Smolen, J., et al. (2004) · Arthritis & Rheumatism · doi:10.1002/art.11487 · Cited by 307
Pentoxifylline suppression of tumor necrosis factor gene transcription.
Doherty, G. M., Jensen, J. C., Alexander, H. R., Buresh, C. M., & Norton, J. A. (1991) · PubMed · Cited by 306
Weisman, M. H., Moreland, L. W., Furst, D. E., Weinblatt, M. E., Keystone, E. C., Paulus, H. E., Teoh, L. S., Velagapudi, R. B., Noertersheuser, P. A., Granneman, G. R., et al. (2003) · Clinical Therapeutics · doi:10.1016/s0149-2918(03)80164-9 · Cited by 303
Yang, X. D., Tisch, R., Singer, S. M., Cao, Z. A., Liblau, R. S., Schreiber, R. D., & McDevitt, H. O. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.3.995 · Cited by 303
Eissner, G., Kolch, W., & Scheurich, P. (2004) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2004.03.011 · Cited by 298
Lymphotoxin/LIGHT, lymphoid microenvironments and autoimmune disease
Gommerman, J. L., & Browning, J. L. (2003) · Nature Reviews Immunology · doi:10.1038/nri1151 · Cited by 292
M-CSF mediates TNF-induced inflammatory osteolysis
Kitaura, H. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26132 · Cited by 292
Gomez-Reino, J. J., Carmona, L., & the BIOBADASER Group (2006) · Arthritis Research & Therapy · doi:10.1186/ar1881 · Cited by 289
Redlich, K., Hayer, S., Maier, A., Dunstan, C. R., Tohidast‐Akrad, M., Lang, S., Türk, B., Pietschmann, P., Woloszczuk, W., Haralambous, S., et al. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10097 · Cited by 285
Design of effective immunotherapy for human autoimmunity
Feldmann, M., & Steinman, L. (2005) · Nature · doi:10.1038/nature03727 · Cited by 277
Mitoma, H., Horiuchi, T., Hatta, N., Tsukamoto, H., Harashima, S.-I., Kikuchi, Y., Otsuka, J., Okamura, S., Fujita, S., & Harada, M. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.11.060 · Cited by 270
Browning, J. L., Allaire, N., Ngam-ek, A., Notidis, E., Hunt, J., Perrin, S., & Fava, R. A. (2005) · Immunity · doi:10.1016/j.immuni.2005.10.002 · Cited by 265
TNF.ALPHA. and pathologic bone resorption
Boyce, B. E., Li, P., Yao, Z., Zhang, Q., Badell, I. R., Schwarz, E. M., O’Keefe, R. J., & Xing, L. (2005) · The Keio Journal of Medicine · doi:10.2302/kjm.54.127 · Cited by 259
Catrina, A. I., Trollmo, C., af Klint, E., Engstrom, M., Lampa, J., Hermansson, Y., Klareskog, L., & Ulfgren, A. K. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20764 · Cited by 255
Self-citationBritish Society for Rheumatology Biologics Register
Silman, A. J., Symmons, D. P. M., Scott, D. G. I., & Griffiths, I. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.suppl_2.ii28 · Cited by 248
Kaine, J., Kivitz, A., Birbara, C. A., & Luo, A. Y. (2007) · PubMed · Cited by 246
Vis, M., Havaardsholm, E. A., Haugeberg, G., Uhlig, T., Voskuyl, A. E., van de Stadt, R. J., Dijkmans, B. A. C., Woolf, A. D., Kvien, T. K., & Lems, W. F. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.044198 · Cited by 246
Effectiveness of TNF-alpha blockade with infliximab in refractory Wegener's granulomatosis
Lamprecht, P. (2002) · Rheumatology · doi:10.1093/rheumatology/41.11.1303 · Cited by 245
Cope, A. P., Londei, M., Chu, N. R., Cohen, S. B., Elliott, M. J., Brennan, F. M., Maini, R. N., & Feldmann, M. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117394 · Cited by 243
Paleolog, E. M., Hunt, M., Elliott, M. J., Feldmann, M., Maini, R. N., & Woody, J. N. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390703 · Cited by 240
Furst, D. E., Wallis, R., Broder, M., & Beenhouwer, D. O. (2006) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2006.02.001 · Cited by 233
Smeets, T. J. M., Kraan, M. C., van Loon, M. E., & Tak, P. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11098 · Cited by 224
Self-citationAdalimumab induces apoptosis of human monocytes: a comparative study with infliximab and etanercept
Shen, C., Assche, G. V., Colpaert, S., Maerten, P., Geboes, K., Rutgeerts, P., & Ceuppens, J. L. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02309.x · Cited by 223
van Vollenhoven, R., Harju, A., Brannemark, S., & Klareskog, L. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.009589 · Cited by 221
Self-citationPathophysiology of severe asthma
Busse, W. W., Banks-Schlegel, S., & Wenzel, S. E. (2000) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2000.111307 · Cited by 218
Suffredini, A. F., Reda, D., Banks, S. M., Tropea, M., Agosti, J. M., & Miller, R. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.10.5038 · Cited by 205
Pasparakis, M., Alexopoulou, L., Grell, M., Pfizenmaier, K., Bluethmann, H., & Kollias, G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.12.6319 · Cited by 205
Koshy, P. J., Henderson, N., Logan, C., Life, P. F., Cawston, T. E., & Rowan, A. D. (2002) · Annals of the Rheumatic Diseases · doi:10.1136/ard.61.8.704 · Cited by 205
Angiogenesis as a target in rheumatoid arthritis
Koch, A. E. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.suppl_2.ii60 · Cited by 204
Tumor necrosis factor inhibitors: Clinical implications of their different immunogenicity profiles
Anderson, P. J. (2005) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2005.01.005 · Cited by 202
Friedmann, E., Hauben, E., Maylandt, K., Schleeger, S., Vreugde, S., Lichtenthaler, S. F., Kuhn, P.-H., Stauffer, D., Rovelli, G., & Martoglio, B. (2006) · Nature Cell Biology · doi:10.1038/ncb1440 · Cited by 201
Ziolkowska, M., Kurowska, M., Radzikowska, A., Luszczykiewicz, G., Wiland, P., Dziewczopolski, W., Filipowicz‐Sosnowska, A., Pazdur, J., Szechinski, J., Kowalczewski, J., et al. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10388 · Cited by 200
Apoptosis in rheumatoid arthritis
Tak, P. P., & Firestein, G. S. (1999) · Apoptosis and Inflammation · doi:10.1007/978-3-0348-8741-0_9 · Cited by 200
Self-citationCarmona, L., & Gómez-Reino, J. J. (2006) · Arthritis Research & Therapy · doi:10.1186/ar1941 · Cited by 195
Biology of tumor necrosis factor‐α– implications for psoriasis
Schottelius, A. J. G., Moldawer, L. L., Dinarello, C. A., Asadullah, K., Sterry, W., & Edwards, C. K. (2004) · Experimental Dermatology · doi:10.1111/j.0906-6705.2004.00205.x · Cited by 195
Eissner, G., Kirchner, S., Lindner, H., Kolch, W., Janosch, P., Grell, M., Scheurich, P., Andreesen, R., & Holler, E. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.12.6193 · Cited by 193
TNF Skews Monocyte Differentiation from Macrophages to Dendritic Cells
Chomarat, P., Dantin, C., Bennett, L., Banchereau, J., & Palucka, A. K. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.5.2262 · Cited by 192
Yao, Z., Li, P., Zhang, Q., Schwarz, E. M., Keng, P., Arbini, A., Boyce, B. F., & Xing, L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512624200 · Cited by 192
Mechanisms of Disease: the link between RANKL and arthritic bone disease
Schett, G., Hayer, S., Zwerina, J., Redlich, K., & Smolen, J. S. (2005) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0036 · Cited by 191
Zhou, H., Jang, H., Fleischmann, R. M., Bouman‐Thio, E., Xu, Z., Marini, J. C., Pendley, C., Jiao, Q., Shankar, G., Marciniak, S. J., et al. (2007) · The Journal of Clinical Pharmacology · doi:10.1177/0091270006298188 · Cited by 191
Lymphotoxin pathway directs thymic Aire expression
Chin, R. K., Lo, J. C., Kim, O., Blink, S. E., Christiansen, P. A., Peterson, P., Wang, Y., Ware, C., & Fu, Y.-X. (2003) · Nature Immunology · doi:10.1038/ni982 · Cited by 190
Alessandri, C., Bombardieri, M., Papa, N., Cinquini, M., Magrini, L., Tincani, A., & Valesini, G. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.014647 · Cited by 188
Montesinos, M. C., Yap, J. S., Desai, A., Posadas, I., McCrary, C. T., & Cronstein, B. N. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200003)43:3<656::aid-anr23>3.0.co;2-h · Cited by 186
Di Sabatino, A. (2004) · Gut · doi:10.1136/gut.53.1.70 · Cited by 186
GRIVENNIKOV, S., TUMANOV, A., LIEPINSH, D., KRUGLOV, A., MARAKUSHA, B., SHAKHOV, A., MURAKAMI, T., DRUTSKAYA, L., FORSTER, I., & CLAUSEN, B. (2005) · Immunity · doi:10.1016/s1074-7613(04)00379-6 · Cited by 185
van der Laken, C. J., Voskuyl, A. E., Roos, J. C., Stigter van Walsum, M., de Groot, E. R., Wolbink, G., Dijkmans, B. A. C., & Aarden, L. A. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.057406 · Cited by 184
Geusens, P. P., Landewé, R. B. M., Garnero, P., Chen, D., Dunstan, C. R., Lems, W. F., Stinissen, P., van der Heijde, D. M. F. M., van der Linden, S., & Boers, M. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21896 · Cited by 182
Ware, C. F., Crowe, P. D., Grayson, M. H., Androlewicz, M. J., & Browning, J. L. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.12.3881 · Cited by 182
Catrina, A. I. (2002) · Rheumatology · doi:10.1093/rheumatology/41.5.484 · Cited by 181
Brennan, F. M., Browne, K. A., Green, P. A., Jaspar, J. M., Maini, R. N., & Feldmann, M. (1997) · Rheumatology · doi:10.1093/rheumatology/36.6.643 · Cited by 179
Bombardieri, S., Ruiz, A. A., Fardellone, P., Geusens, P., McKenna, F., Unnebrink, K., Oezer, U., Kary, S., Kupper, H., Burmester, G. R., et al. (2007) · Rheumatology · doi:10.1093/rheumatology/kem091 · Cited by 179
Landewé, R., van der Heijde, D., Klareskog, L., van Vollenhoven, R., & Fatenejad, S. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22143 · Cited by 177
Self-citationCharacterization of lymphotoxin-alpha beta complexes on the surface of mouse lymphocytes
Browning, J. L., Sizing, I. D., Lawton, P., Bourdon, P. R., Rennert, P. D., Majeau, G. R., Ambrose, C. M., Hession, C., Miatkowski, K., Griffiths, D. A., et al. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.7.3288 · Cited by 176
Finckh, A., Simard, J. F., Gabay, C., & Guerne, P.-A. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.045062 · Cited by 176
Evans, T. J., Moyes, D., Carpenter, A., Martin, R., Loetscher, H., Lesslauer, W., & Cohen, J. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.6.2173 · Cited by 174
Ulfgren, A. K., Lindblad, S., Klareskog, L., Andersson, J., & Andersson, U. (1995) · Annals of the Rheumatic Diseases · doi:10.1136/ard.54.8.654 · Cited by 173
Self-citationElkayam, O. (2004) · Seminars in Arthritis and Rheumatism · doi:10.1053/j.semarthrit.2003.10.003 · Cited by 173
de Rycke, L., Baeten, D., Kruithof, E., Van den Bosch, F., Veys, E. M., & de Keyser, F. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21190 · Cited by 172
TNF induces internalization of the p60 receptor and shedding of the p80 receptor.
Higuchi, M., & Aggarwal, B. B. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.7.3550 · Cited by 171
KRISTENSEN, M., CHU, C. Q., EEDY, D. J., FELDMANN, M., BRENNAN, F. M., & BREATHNACH, S. M. (2008) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.1993.tb03457.x · Cited by 171
Zeltser, R., Valle, L., Tanck, C., Holyst, M. M., Ritchlin, C. T., & Gaspari, A. A. (2001) · PubMed · Cited by 169
Kraan, M. C., Reece, R. J., Barg, E. C., Smeets, T. J. M., Farnell, J., Rosenburg, R., Veale, D. J., Breedveld, F. C., Emery, P., & Tak, P. P. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200008)43:8<1820::aid-anr18>3.0.co;2-d · Cited by 166
Self-citationPalmqvist, P., Lundberg, P., Persson, E., Johansson, A., Lundgren, I., Lie, A., Conaway, H. H., & Lerner, U. H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m510160200 · Cited by 166
Secreted Lymphotoxin-α Is Essential for the Control of an Intracellular Bacterial Infection
Roach, D. R., Briscoe, H., Saunders, B., France, M. P., Riminton, S., & Britton, W. J. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.2.239 · Cited by 163
den Broeder, A. A., Joosten, L. A. B., Saxne, T., Heinegård, D., Fenner, H., Miltenburg, A. M. M., Frasa, W. L. H., van Tits, L. J., Buurman, W. A., van Riel, P. L. C. M., et al. (2002) · Annals of the Rheumatic Diseases · doi:10.1136/ard.61.4.311 · Cited by 161
Lorenz, H., Antoni, C., Valerius, T., Repp, R., Grünke, M., Schwerdtner, N., Nüßlein, H. G., Woody, J. N., Kalden, J. R., & Manger, B. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.4.1646 · Cited by 160
Autoimmunity and Anti-TNF-α Agents
ATZENI, F., TURIEL, M., CAPSONI, F., DORIA, A., MERONI, P., & SARZI-PUTTINI, P. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1361.100 · Cited by 160
Mast cells are an important cellular source of tumour necrosis factor α in human intestinal tissue
Bischoff, S. C., Lorentz, A., Schwengberg, S., Weier, G., Raab, R., & Manns, M. P. (1999) · Gut · doi:10.1136/gut.44.5.643 · Cited by 158
Pneumococcal vaccine response in psoriatic arthritis patients during treatment with etanercept.
Mease, P. J., Ritchlin, C. T., Martin, R. W., Gottlieb, A. B., Baumgartner, S. W., Burge, D. J., & Whitmore, J. B. (2004) · PubMed · Cited by 157
Swedish registers to examine drug safety and clinical issues in RA
Askling, J., Fored, C. M., Geborek, P., Jacobsson, L. T. H., van Vollenhoven, R., Feltelius, N., Lindblad, S., & Klareskog, L. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.045872 · Cited by 157
Self-citationHaynes, D. R. (2003) · Rheumatology · doi:10.1093/rheumatology/keg047 · Cited by 157
Cutting Edge: Tissue Inhibitor of Metalloproteinase 3 Regulates TNF-Dependent Systemic Inflammation
Smookler, D. S., Mohammed, F. F., Kassiri, Z., Duncan, G. S., Mak, T. W., & Khokha, R. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.2.721 · Cited by 154
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007
Furst, D. E., Breedveld, F. C., Kalden, J. R., Smolen, J. S., Burmester, G. R., Sieper, J., Emery, P., Keystone, E., Schiff, M., Mease, P. J., et al. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.081430 · Cited by 153
Cited by
Glutamate neurotoxicity and diseases of the nervous system
CHOI, D. (1988) · Neuron · doi:10.1016/0896-6273(88)90162-6 · Cited by 7,972
Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease
Turner, M. D., Nedjai, B., Hurst, T., & Pennington, D. J. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.05.014 · Cited by 2,162
Cytokines in Inflammatory Disease
Kany, S., Vollrath, J. T., & Relja, B. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20236008 · Cited by 1,971
Tumour necrosis factor and cancer
Balkwill, F. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2628 · Cited by 1,915
Jang, D.-I., Lee, A.-H., Shin, H.-Y., Song, H.-R., Park, J.-H., Kang, T.-B., Lee, S.-R., & Yang, S.-H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052719 · Cited by 1,694
Metadata
- Authors
- Tracey, D., Klareskog, L., Sasso, E. H., Salfeld, J. G., & Tak, P. P.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2008-02
- Volume
- 117
- Issue
- 2
- Pages
- 244-279
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W1997106678
- Cited by
- 1,628
- References
- 291
- FWCI
- 55.22
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.